Exclusive: Britons found to have ‘lost out’ while rest of Europe benefits from golden age of research and treatments
‘Children with cancer cannot wait’: the human cost of clinical trial delays after Brexit
British cancer patients are being denied life-saving drugs and trials of revolutionary treatments are being derailed by the red tape and extra costs brought on by Brexit, a damning report warns.
Soaring numbers are being diagnosed with the disease amid a growing and ageing population, improved diagnosis initiatives and wider public awareness – making global collaborations to find new medicines essential.
About Author
More Stories
Researchers create AI-based tool that restores age-damaged artworks in hours
23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
European journalists targeted with Paragon Solutions spyware, say researchers